Glucose Health, Inc. (OTCMKTS:GLUC – Get Free Report) was the recipient of a large growth in short interest in the month of September. As of September 30th, there was short interest totaling 888 shares. Based on an average trading volume of 26,004 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are short sold.
Key Stories Impacting Glucose Health
Here are the key news stories impacting Glucose Health this week:
- Positive Sentiment: Growing coverage of diabetes management—including continuous glucose monitors, dietary strategies and diabetes-remission research—could increase consumer interest in blood-sugar products and services, a potentially supportive backdrop for GLUC’s category. Continuous Glucose Monitors Help Type 2 Diabetes Patients Spend Five More Hours a Day in Healthy Blood Sugar Range Type 2 Diabetes Went Into Remission for 54% of Patients After Making 2 Changes
- Neutral Sentiment: Recent articles discuss blood-sugar differences among protein shakes, fruits, sardines, high-protein snacks, sourdough and meal timing. They may raise awareness of glucose control but do not mention Glucose Health, its products or financial outlook. Protein Shakes and Blood Sugar Blueberries vs Grapes High-Protein Snacks Sardines and Blood Sugar
- Neutral Sentiment: Additional coverage focuses on diabetes warning signs, prediabetes reversal, mineral levels, GLP-1 medication use, educational resources and community workshops. These stories support broad sector awareness but provide no identifiable catalyst for GLUC. Prediabetes Prevention Mineral Levels and Blood Sugar GLP-1 Medication Mistake Nutritional Resources for Diabetes
- Neutral Sentiment: Comparisons involving oranges, citrus, grapes and raisins, along with research suggesting that some blood-sugar fluctuation may be harmless, add mixed but non-company-specific information. Oranges vs. Sumo Citrus Blood Sugar Fluctuations Grapes vs. Raisins
Glucose Health Trading Up 20.0%
Shares of GLUC stock traded up $0.06 during trading hours on Thursday, hitting $0.36. 7,000 shares of the company were exchanged, compared to its average volume of 21,833. The stock has a market capitalization of $10.11 million, a price-to-earnings ratio of -12.00 and a beta of 1.10. The firm has a fifty day simple moving average of $0.35 and a 200 day simple moving average of $0.38. Glucose Health has a 52-week low of $0.02 and a 52-week high of $0.67.
Glucose Health (OTCMKTS:GLUC – Get Free Report) last posted its quarterly earnings data on Friday, August 14th. The company reported ($0.01) EPS for the quarter. The company had revenue of $0.04 million during the quarter.
About Glucose Health
Glucose Health, Inc is a consumer health company focused on developing and marketing nutritional products intended to support healthy blood glucose levels and metabolic wellness. The company’s offerings are positioned as dietary supplements and functional nutrition products rather than prescription medicines.
Its principal product has been GlucoDown, a powdered drink mix marketed for use as part of a daily wellness routine. The product is formulated with nutritional ingredients intended to support blood sugar management, and is sold directly to consumers through online channels.
Publicly available information about Glucose Health’s operating history, geographic reach, and current leadership is limited.
See Also
- Five stocks we like better than Glucose Health
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Glucose Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Glucose Health and related companies with MarketBeat.com's FREE daily email newsletter.
